The Use of Immunotoxins Containing Ricin A or B Chains to Kill Neoplastic B Cells
- 1 June 1985
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 446 (1), 228-236
- https://doi.org/10.1111/j.1749-6632.1985.tb18403.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrowBlood, 1983
- Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugateNature, 1982
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- Immunotoxins: Hybrid Molecules Combining High Specificity and Potent CytotoxicityImmunological Reviews, 1982
- Neoplastic B Cells as Targets for Antibody‐Ricin A Chain ImmunotoxinsImmunological Reviews, 1982
- The Preparation and Cytotoxic Properties of Antibody‐Toxin ConjugatesImmunological Reviews, 1982
- Monoclonal Antibody‐Ricin or Ricin A Chain Hybrids: Kinetic Analysis of Cell Killing for Tumor TherapyImmunological Reviews, 1982
- Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.Proceedings of the National Academy of Sciences, 1980
- Spontaneous murine B-cell leukaemiaNature, 1978
- Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibiting protein synthesisBiochemistry, 1973